er than the market in India
. Piramal has a strong commercial presence, including the largest sales force in India
with a unique model that includes dedicated sales personnel in rural areas inhabited by 70 percent of the population. The combined Abbott and Piramal sales forces will be the industry's largest in India
Piramal's Healthcare Solutions business will become part of Abbott's newly created, stand-alone Established Products Division. Piramal's Healthcare Solutions business employs more than 5,000 people in India. Abbott, which is celebrating its 100th year in India, has more than 2,500 employees across all of its businesses there.
Abbott's Established Products Strategy
Throughout the past decade, Abbott has built a leading portfolio of branded generics, through its own products as well as those acquired with the 2001 acquisition of Knoll's pharmaceutical business. In 2007, the company established a separate business unit within its international pharmaceutical division dedicated to established products.
Additionally, a new geographic region focused on Russia, India and China was created, which resulted in the doubling of Abbott's growth rate in those countries.
Most recently, the company acquired Solvay Pharmaceuticals, obtaining a diverse branded generics portfolio and providing significant critical mass in key emerging markets.
As a result of these combined actions, Abbott is now among the leading multinational health care companies in numerous emerging markets. Approximately 2Page: 1 2 3 4 5 6 Related biology technology :1
. Abbott Named One of the Best Places to Launch a Career by BusinessWeek2
. Martek Signs Multi-Year Worldwide Sole Source Supply Agreement with Abbott3
. Abbott Scientists Create One Molecule With Two Antibody Functions4
. Abbott Named to Science Magazines List of Top Employers in the Biotech and Pharmaceutical Industry5
. Abbotts HUMIRA(R) Receives Positive Opinion From EMEA for Treatment of Moderate to Severe Plaque Psoriasis6
. Abbott Declares 336th Consecutive Quarterly Dividend7
. Pfizer, Genentech, Amgen, Bayer, Wyeth, Abbott, Merck and Additional Leading Pharmaceutical Companies Participating During ExL Pharmas Fall Line Up!8
. Abbott to Present at JP Morgan Healthcare Conference9
. Abbott Announces Approval of First Fully Automated Blood Screening Test for HTLV-I/HTLV-II10
. Isis Announces Equity Investment in Ibis Biosciences Subsidiary by Abbott; Option Acquired to Purchase Remaining Ibis Equity11
. Abbott Receives FDA Approval for SIMCOR(R) (Niaspan(R) / simvastatin), a Novel Combination Medicine for Comprehensive Cholesterol Management